Jonathan Garcia

Dr. Jonathan Garcia

orcid

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2024 in International Journal of Heart Failure
Verified
Journal Article
Open access
PDF file
KCKevin José Cruz-Mora
Kevin José Cruz-Mora
Sebastián Arguedas-ChacónSebastián Arguedas-Chacón
Sebastián Arguedas-Chacón
AQAlonso Quirós-Romero
Alonso Quirós-Romero
Jose Miguel Chaverri-FernandezJose Miguel Chaverri-Fernandez
Jose Miguel Chaverri-Fernandez
BSBruno Serrano-Arias
Bruno Serrano-Arias
MSMario Speranza
Mario Speranza
Zavaleta-Monestel E, et al. Int J Heart Fail. 2024 Jan;6(1):1-10. https://doi.org/10.36628/ijhf.2023.0022

Verified
Journal Article
Open access
PDF file
KCKevin José Cruz-Mora
Kevin José Cruz-Mora
CRCarolina Rojas-Chinchilla
Carolina Rojas-Chinchilla
AAAdriana Anchía-Alfaro
Adriana Anchía-Alfaro
DQDiego Quesada-Loría
Diego Quesada-Loría
JGJonathan Garcia
Jonathan Garcia
GHGeorgia Hanley-Vargas
Georgia Hanley-Vargas
Laboratory-acquired infections (LAIs) pose significant risks to laboratory personnel, public health, and the environment, despite the implementation of biosafety measures. This study provides a comprehensive analysis of global LAIs reported from 1974 to 2024, identifying trends, causes, and pathogen distributions to address gaps in biosafety knowledge. A systematic literature review was conducted using databases such as PubMed, Cochrane, Google Scholar, and the American Biological Safety Association (ABSA). A total of 234 studies meeting strict inclusion criteria were analyzed. Bacterial pathogens accounted for 58.6% of reported incidents, followed by viruses at 36.1%. Procedural errors and accidents were the predominant causes of LAIs, with Brucella spp. being the most frequently reported pathogen, primarily in China. Temporal trends indicated a decline in incidents coinciding with the implementation of international biosafety regulations. However, disparities in incident reporting and compliance remain evident across countries. This study underscores the urgent need for a global regulatory framework, mandatory biosafety audits, a centralized incident database, and standardized training for high-containment laboratory personnel. Enhancing global collaboration, transparency in research, and adherence to ethical standards will further reduce LAI risks and strengthen public health security worldwide.

9 February 2024 in Current Dermatology Reports
Verified
Journal Article
Closed access
PDF file
Francesco FerraraFrancesco Ferrara
Francesco Ferrara
AZAndrea Zovi
Andrea Zovi
MCMaurizio Capuozzo
Maurizio Capuozzo
JGJonathan Garcia
Jonathan Garcia
KCKevin José Cruz-Mora
Kevin José Cruz-Mora
RLRoberto Langella
Roberto Langella

1 December 2025 in Coronaviruses
Verified
Journal Article
Closed access
PDF file
KCKevin José Cruz-Mora
Kevin José Cruz-Mora
Sebastián Arguedas-ChacónSebastián Arguedas-Chacón
Sebastián Arguedas-Chacón
RQRicardo Quesada-Villasenor
Ricardo Quesada-Villasenor
JGJonathan Garcia
Jonathan Garcia
JCJeimy Campos-Hernandez
Jeimy Campos-Hernandez
AZAndrea Zovi
Andrea Zovi
Long COVID is a syndrome with common symptoms such as dyspnea, fatigue, cognitive dysfunction, chest pain, and other conditions that have a major impact on affected patients. These are some of the risk factors of fluctuating or relapsing states that occur in patients with a history of SARS-CoV-2 infection of at least 2 months. This study addressed the challenges faced by healthcare professionals in defining and managing this condition, which manifests with diverse and inconsistent symptoms that last more than three months after infection. A systematic review of the literature over the period 2020-2023 has been conducted to focus on the evolution of the long COVID phenomenon worldwide. The study aimed to describe the spectrum of symptoms associated with Long COVID by comparing management approaches in European and Latin American countries. Disparities in research, guidelines, and treatment strategies between these regions have been identified, posing challenges for accurate diagnosis and effective treatment in Latin America. It is crucial to propose further studies and research on the mechanistic understanding of the symptoms of long COVID and the development of targeted treatments. Eventually, it is critical to address the wide disparities in long COVID research and treatment between Europe and Latin America to ensure equitable access to information and health care for people affected, considering both physical and mental health aspects.

1 July 2025 in Current Drug Therapy
Verified
Journal Article
Closed access
PDF file
KCKevin José Cruz-Mora
Kevin José Cruz-Mora
JGJonathan Garcia
Jonathan Garcia
Sebastián Arguedas-ChacónSebastián Arguedas-Chacón
Sebastián Arguedas-Chacón
CRCarolina Rojas-Chinchilla
Carolina Rojas-Chinchilla
RQRicardo Quesada-Villasenor
Ricardo Quesada-Villasenor
RMRenato Murillo
Renato Murillo
Currently, studies on various natural products that aid in wound healing have seen significant growth. Betulin and its derivative, betulinic acid, are triterpenes abundant in the leaves and barks of certain species, such as birch, which has been of particular interest. Clinical and preclinical studies have demonstrated their ability to accelerate wound healing, as well as other properties such as antimicrobial, anti-inflammatory action, and anti-cancer properties, and beneficial effects on HIV, diabetes mellitus, and cardiovascular disorders. However, further research focusing exclusively on betulin and betulinic acid is needed to better understand its therapeutic potential and develop new medications for effective management. These advancements could greatly enhance the treatment of wounds, skin lesions and other diseases, offering more effective and safer therapeutic options to improve the quality of life of the population.

4 July 2024 in Crónicas científicas
Verified
Journal Article
Closed access
KCKevin José Cruz-Mora
Kevin José Cruz-Mora
ZRZoe Rojas-Barrantes
Zoe Rojas-Barrantes
Sebastián Arguedas-ChacónSebastián Arguedas-Chacón
Sebastián Arguedas-Chacón
JDJosé M Díaz-Madriz
José M Díaz-Madriz
JGJonathan Garcia
Jonathan Garcia
Jose Miguel Chaverri-FernandezJose Miguel Chaverri-Fernandez
Jose Miguel Chaverri-Fernandez
Costa Rica posee un sistema de salud universal para sus habitantes, con importantes retos de mejora en aspectos como recurso humano e infraestructura, sin embargo, se ha determinado a lo largo de la historia que una de las fortalezas de este sistema tanto en atención primaria como servicios médicos especializados, es la figura del farmacéutico. Si bien estos profesionales de salud tienen la oportunidad de ejercer en diversos campos, incluidos asuntos regulatorios, representación médica, farmacovigilancia, fabricación de medicamentos y más, esta revisión enfatizará específicamente las dos áreas clínicas principales de las ciencias farmacéuticas que son la farmacia comunitaria y hospitalaria. Exploraremos los papeles importantes que desempeñan los farmacéuticos en estos ámbitos y que, gracias a su conocimiento, arduo trabajo y dedicación para mejorar el acceso y la calidad en el manejo de los medicamentos, estos profesionales se han convertido en miembros esenciales del equipo multidisciplinario de salud.